Noticias de JNJ

Noticias del mercado

Últimas noticias sobre JNJ — 517 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: JNJ ✕ 517 resultados
01/04/2026 JNJ_US — Yahoo Finance
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal
31/03/2026 JNJ_US — Investor's Business Daily ES ← EN
Por qué las acciones del día de IBD J&J se están recuperando, finalmente
31/03/2026 JNJ_US — Yahoo Finance ES ← EN
Jim Cramer destaca la “caída libre” y el aumento de las acciones de Johnson & Johnson a pesar de las demandas
30/03/2026 JNJ_US — Yahoo Finance
Johnson & Johnson’s JNJ-4804 Deal Adds Weight To Immunology Story
30/03/2026 JNJ_US — Yahoo Finance
Will ICOTYDE’s First‑in‑Class Oral Psoriasis Launch Redefine Johnson & Johnson’s (JNJ) Immunology Narrative?
29/03/2026 JNJ_US — University of San Diego
No More Tears: The Dark Secrets of Johnson & Johnson
25/03/2026 JNJ_US — Seeking Alpha
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios (NYSE:JNJ)
25/03/2026 JNJ_US — Barron's
Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets
24/03/2026 JNJ_US — Yahoo Finance
Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances
24/03/2026 JNJ_US — Medical Design & Outsourcing
Johnson & Johnson discloses executive pay, denies them a talc fight ‘windfall’
19/03/2026 JNJ_US — The Motley Fool
2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow
19/03/2026 JNJ_US — Yahoo Finance
Johnson & Johnson announces U.S. FDA approved Icotyde
19/03/2026 JNJ_US — Yahoo Finance
Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business
18/03/2026 JNJ_US — BBC ES ← EN
Un grupo escocés demanda a Johnson & Johnson por acusaciones de cáncer con polvos de talco
17/03/2026 JNJ_US — Yahoo Finance ES ← EN
Las acciones de Johnson & Johnson (JNJ) caen a medida que sube el mercado: hechos que debe saber antes de operar
17/03/2026 JNJ_US — Yahoo Finance
Why One Analyst Thinks Johnson & Johnson Reaches $280
14/03/2026 JNJ_US — Yahoo Finance ES ← EN
La actualización del ensayo contra el cáncer de Johnson & Johnson sitúa a Erda-iDRS en el centro de la valoración
11/03/2026 JNJ_US — Yahoo Finance
How The Johnson & Johnson (JNJ) Narrative Is Shifting With Pipeline Rethinks And New Valuation Targets
05/03/2026 JNJ_US — Johnson & Johnson
Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line
04/03/2026 JNJ_US — Reuters
Johnson & Johnson launches website for direct-to-consumer sales

Página 25 de 26

keyboard_arrow_up